Kimberly Gentile

Insider Reports History

Entity
Individual
Location
C/O Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kimberly Gentile:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Ltd. SVP, Clinical Operations Stock Options (Right to buy) 96.3K Jan 2, 2024 Direct
Biohaven Pharmaceutical Holding Co Ltd. SVP, Clinical Operations Common Shares 0 $148.50 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. SVP, Clinical Operations Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. SVP, Clinical Operations Stock Options (Right to Buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by Kimberly Gentile

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BHVN Biohaven Ltd. Jan 2, 2024 1 $0 4 Jan 4, 2024 SVP, Clinical Operations
BHVN Biohaven Ltd. Nov 2, 2023 1 $0 4 Nov 6, 2023 SVP, Clinical Operations
BHVN Biohaven Ltd. Oct 3, 2022 42 $18.7K 4 Oct 5, 2022 SVP, Clinical Operations
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 16 -$1.73M 4 Oct 3, 2022 SVP, Clinical Operations
BHVN Biohaven Ltd. Sep 28, 2022 0 $0 3 Sep 30, 2022 SVP, Clinical Operations
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 6, 2022 5 -$223K 4 Jan 7, 2022 SVP, Clinical Operations
BHVN Biohaven Pharmaceutical Holding Co Ltd. Nov 25, 2021 3 -$201K 4 Nov 26, 2021 SVP, Clinical Operations